Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Revolution Medicines Inc. Common Stock (RVMD) vs Taiwan Semiconductor Mfg. Co. Ltd. (TSM) Price & Performance

Revolution Medicines Inc. Common StockTrade
Taiwan Semiconductor Mfg. Co. Ltd.Trade

Price performance (Past 24H)

Key statistics

Revolution Medicines Inc. Common Stock vs Taiwan Semiconductor Mfg. Co. Ltd. — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.1 (market cap $40.32B), while Taiwan Semiconductor Mfg. Co. Ltd. trades at $464.84 (market cap $2.07T). The key difference: Taiwan Semiconductor Mfg. Co. Ltd. is far larger — about 51.3× Revolution Medicines Inc. Common Stock's market cap, and Taiwan Semiconductor Mfg. Co. Ltd. pays a 0.89% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Taiwan Semiconductor Mfg. Co. Ltd. for 110 Days on average.

RVMDTSM
Market Cap
$40.32B$2.07T
Volume
4,855,73413,244,224
Sector
HealthTechnology
52-Week High
$221.15$485.80
52-Week Low
$47.50$275.06
Typical Hold Time
0 Days110 Days
Enterprise Value
$37.02B$1.99T
Dividend Yield
—0.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Revolution Medicines Inc. Common Stock

No Aura AI signal available yet.

Taiwan Semiconductor Mfg. Co. Ltd.

TSM trades at $472.20, down 2.09% today, but maintains strong technical momentum with bullish moving averages and support at $470. The company demonstrates exceptional fundamentals with 44.6% net margins and consistent earnings beats, including Q2 2026 EPS of $4.22 beating estimates by 10.8%. Revenue growth accelerated to $3.81T in 2025, up 31.6% year-over-year, driven by AI chip demand and technological leadership.

Outlook remains positive with 72% analyst buy ratings and $578.43 consensus target implying 22.5% upside. Key risks include geopolitical tensions in Taiwan and cyclical semiconductor demand. The stock presents a compelling growth opportunity given its dominant foundry position and expanding AI infrastructure investments.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RVMD
100% Buy0% Sell
Avg holding period · 0 Days
TSM
64% Buy36% Sell
Avg holding period · 110 Days

Top news

Latest headlines on both assets

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →

About Taiwan Semiconductor Mfg. Co. Ltd.

Taiwan Semiconductor Manufacturing Company, or TSMC, is the world's largest dedicated chip foundry, with over 57% market share in 2021 per Gartner. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the U.S. in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs.

Read more on TSM →